Fulcrum Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| FULC | FATE | FTRE | FTH | DSGN | ZVRA | |
|---|---|---|---|---|---|---|
| Market cap | 287.96M | 250.42M | 2.01B | 516.62M | 665.24M | 663.32M |
| P/E (TTM) | — | — | — | — | — | 9.2 |
| Forward P/E | -6.9 | -2.2 | 18.6 | -5.4 | -6.6 | 10.4 |
| Price/book | 0.9 | 1.6 | 3.8 | 1.4 | 3.3 | 4.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −52.48% | +87.16% | +75.31% | +121.53% | +57.86% | +1.89% |
| Today | +0.80% | +2.45% | −0.57% | +1.73% | +2.80% | +8.87% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All FULC news ›Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Stock Has Consensus Price Target of $8.20
Posted by Michael Walen on Oct 24th, 2026 Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Fulcrum Therapeutics in a report on Thursday, October 15th. View Our Latest Stock Analysis on Fulcrum Therapeutics Shares of…
More from 1 other outlet
Head-To-Head Survey: Biorestorative Therapies (NASDAQ:BRTX) & Fulcrum Therapeutics (NASDAQ:FULC)
Posted by Danessa Lincoln on Oct 4th, 2026 Fulcrum Therapeutics (NASDAQ:FULC – Get Free Report) and Biorestorative Therapies (NASDAQ:BRTX – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- themarketsdaily.com2
- defenseworld.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.